F. Hoffmann-La Roche Ltd received approval from the Food and Drug Administration (FDA) for its Evrysdi, a prescription medicine, to treat spinal muscular atrophy (SMA) in babies under two months of age.
The Food and Drug Administration (FDA) provided the clearance for the utilization of dIFine, a digital immunofluorescence system developed by Zeus Scientific Inc.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?